Harvard Bioscience, Inc. (HBIO)
HBIO Stock Price Chart
Explore Harvard Bioscience, Inc. interactive price chart. Choose custom timeframes to analyze HBIO price movements and trends.
HBIO Company Profile
Discover essential business fundamentals and corporate details for Harvard Bioscience, Inc. (HBIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
19 Mar 2001
Employees
330.00
CEO
James W. Green
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
HBIO Financial Timeline
Browse a chronological timeline of Harvard Bioscience, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.01, while revenue estimate is $20.00M.
Earnings released on 11 Aug 2025
EPS came in at -$0.01 surpassing the estimated -$0.03 by +60.00%, while revenue for the quarter reached $20.45M , beating expectations by +7.63%.
Earnings released on 12 May 2025
EPS came in at -$0.01 surpassing the estimated -$0.02 by +50.00%, while revenue for the quarter reached $21.77M , beating expectations by +1.75%.
Earnings released on 12 Mar 2025
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $24.56M , beating expectations by +17.21%.
Earnings released on 7 Nov 2024
EPS came in at -$0.02 falling short of the estimated $0.05 by -140.00%, while revenue for the quarter reached $21.97M , missing expectations by -9.03%.
Earnings released on 8 Aug 2024
EPS came in at -$0.03 falling short of the estimated $0.05 by -160.00%, while revenue for the quarter reached $23.10M , missing expectations by -12.51%.
Earnings released on 7 May 2024
EPS came in at $0.02 falling short of the estimated $0.02 by -14.27%, while revenue for the quarter reached $24.51M , missing expectations by -4.96%.
Earnings released on 7 Mar 2024
EPS came in at $0.04 falling short of the estimated $0.05 by -20.00%, while revenue for the quarter reached $28.15M , missing expectations by -3.29%.
Earnings released on 7 Nov 2023
EPS came in at $0.01 falling short of the estimated $0.04 by -75.00%, while revenue for the quarter reached $25.36M , missing expectations by -13.73%.
Earnings released on 8 Aug 2023
EPS came in at $0.04 falling short of the estimated $0.05 by -20.00%, while revenue for the quarter reached $28.76M , missing expectations by -3.01%.
Earnings released on 25 Apr 2023
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $29.98M , beating expectations by +1.10%.
Earnings released on 9 Mar 2023
EPS came in at $0.04 surpassing the estimated $0.03 by +20.01%, while revenue for the quarter reached $28.43M , missing expectations by -6.27%.
Earnings released on 8 Nov 2022
EPS came in at -$0.01 falling short of the estimated $0.05 by -120.00%, while revenue for the quarter reached $26.92M , missing expectations by -6.74%.
Earnings released on 3 Aug 2022
EPS came in at $0.05 falling short of the estimated $0.06 by -16.67%, while revenue for the quarter reached $29.21M , missing expectations by -4.19%.
Earnings released on 4 May 2022
EPS came in at $0.04 falling short of the estimated $0.05 by -20.00%, while revenue for the quarter reached $28.78M , beating expectations by +0.03%.
Earnings released on 8 Mar 2022
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $33.06M , beating expectations by +0.28%.
Earnings released on 3 Nov 2021
EPS came in at $0.06 matching the estimated $0.06, while revenue for the quarter reached $29.66M , beating expectations by +6.28%.
Earnings released on 5 Aug 2021
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $29.20M , beating expectations by +3.76%.
Earnings released on 6 May 2021
EPS came in at $0.05 surpassing the estimated $0.03 by +50.02%, while revenue for the quarter reached $26.99M , beating expectations by +21.21%.
Earnings released on 10 Mar 2021
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $30.98M .
Earnings released on 5 Nov 2020
EPS came in at $0.04 surpassing the estimated $0.04 by +14.29%, while revenue for the quarter reached $24.04M , meeting expectations.
HBIO Stock Performance
Access detailed HBIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.